We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

124 hedge funds and large institutions have $292M invested in Solid Biosciences in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 15

169% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 16

101% more capital invested

Capital invested by funds: $145M → $292M (+$146M)

38% more funds holding

Funds holding: 90 → 124 (+34)

10.83% more ownership

Funds ownership: 90.92% → 101.75% (+11%)

0% more call options, than puts

Call options by funds: $714K | Put options by funds: $714K

Holders
124
Holders Change
+34
Holders Change %
+37.78%
% of All Funds
1.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
43
Reduced
16
Closed
15
Calls
$714K
Puts
$714K
Net Calls
–
Net Calls Change
-$2.28M

Top Buyers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
+$24.9M
2
PA
Perceptive Advisors
New York
+$21.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.3M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$16.6M
5
SL
Siren LLC
Connecticut
+$15.7M

Top Sellers

Rank Fund Capital Flow
1
VPC
Vestal Point Capital
New York
-$4.69M
2
JP Morgan Chase
JP Morgan Chase
New York
-$4.02M
3
LCM
Laurion Capital Management
New York
-$1.02M
4
Millennium Management
Millennium Management
New York
-$793K
5
N
Nuveen
North Carolina
-$661K
Name Holding Trade Value Shares
Change 		Change in
Stake
QPW
51
Quantum Private Wealth
Florida
$262K +$57.8K +13,500 +24%
BFM
52
Boothbay Fund Management
New York
$259K +$299K +69,874 New
Two Sigma Investments
53
Two Sigma Investments
New York
$257K -$285K -66,651 -49%
Charles Schwab
54
Charles Schwab
California
$254K +$22.3K +5,220 +8%
Barclays
55
Barclays
United Kingdom
$225K +$26.3K +6,131 +11%
Walleye Capital
56
Walleye Capital
New York
$204K -$444K -103,602 -65%
Bank of New York Mellon
57
Bank of New York Mellon
New York
$194K +$1.03K +241 +0.5%
American Century Companies
58
American Century Companies
Missouri
$192K +$21.3K +4,978 +11%
N
59
Nuveen
North Carolina
$161K -$661K -154,350 -78%
AI
60
Atom Investors
Texas
$152K +$175K +40,987 New
XT
61
XTX Topco
Cayman Islands
$151K +$175K +40,930 New
Invesco
62
Invesco
Georgia
$149K +$120K +27,943 +228%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$146K -$18.2K -4,255 -10%
FRM
64
Fox Run Management
Connecticut
$141K +$164K +38,226 New
QC
65
Quadrature Capital
United Kingdom
$138K +$160K +37,325 New
Bank of America
66
Bank of America
North Carolina
$136K -$200K -46,828 -56%
ACM
67
ADAR1 Capital Management
Texas
$128K -$490K -114,424 -77%
Allianz Asset Management
68
Allianz Asset Management
Germany
$100K +$116K +27,100 New
VF
69
Virtu Financial
New York
$95K +$110K +25,742 New
SWA
70
SFMG Wealth Advisors
Texas
$92.6K +$107K +25,031 New
CIBC Private Wealth Group
71
CIBC Private Wealth Group
Georgia
$81.7K +$131K +30,600 New
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$78K -$98.7K -23,043 -52%
Lido Advisors
73
Lido Advisors
California
$74.7K +$86.4K +20,189 New
HSBC Holdings
74
HSBC Holdings
United Kingdom
$69.8K +$390 +91 +0.5%
Citigroup
75
Citigroup
New York
$66.9K +$1.83K +428 +2%
1 2
3
4 5

SLDB Hedge Fund Activity: Q1 2025 in Review

124 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2025, worth a combined $292M — up 101% from $145M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new SLDB positions and 15 closed out — a net gain of 34 holders — while 43 added to existing stakes and 16 trimmed.

The largest buyer was Commodore Capital, opening a new position worth an estimated $24.9M. The largest seller was Vestal Point Capital, cutting an estimated $4.69M.

  • 124 institutional investors held Solid Biosciences (SLDB) as of Q1 2025, up from 90 in Q4 2024.
  • Funds reported $292M of Solid Biosciences stock for Q1 2025, up 101% quarter-over-quarter.
  • 49 funds opened new Solid Biosciences positions in Q1 2025 and 15 closed out, a net change of +34 holders.
  • The largest Solid Biosciences buyer in Q1 2025 was Commodore Capital, an estimated $24.9M added.
  • The largest Solid Biosciences seller in Q1 2025 was Vestal Point Capital, an estimated $4.69M sold.

Based on aggregated 13F filings for Q1 2025.